ArgentumArgentumArgentumArgentum
  • ABOUT US
  • APPROACH
    • INVESTMENT STRATEGY
    • INVESTMENT CRITERIA
    • SECTORS
  • TEAM
  • PORTFOLIO
  • NEWS
  • INVESTORS
  • CONTACT US

News

All News Portfolio News Argentum News

ANI to Acquire Two NDAs from Merck for $75 Million

September 21st, 2015

Baudette, MN – September 21, 2015 – ANI Pharmaceuticals, Inc. (“ANI”) (NASDAQ: ANIP) today announced that it has agreed to acquire the NDAs for purified corticotropin gel and corticotropin zinc hydroxide from Merck (known as MSD outside of the United States and Canada) for $75 million in cash and a percentage of future net sales.Read more >

ANI Prices $125MM Notes

December 5th, 2014

Baudette, MN – December 5, 2014  – ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (the “Company”) today announced the pricing of an underwritten public offering of $125,000,000 aggregate principal amount of its 3.00% Convertible Senior Notes due 2019 (the “Notes”).  The aggregate principal offering amount was increased from the previously announced offering size of $100,000,000.  The underwriters have a 30-day option toRead more >

ANI Closes Public Offering

March 10th, 2014

BAUDETTE, Minn., March 10, 2014 — ANI Pharmaceuticals, Inc. (the “Company”) (ANIP), today announced the closing of its previously announced underwritten public offering of 1,612,903 shares of common stock, at a price to the public of $31.00 per share and for gross proceeds of $50.0 million. The shares include 210,378 shares of common stock soldRead more >

ANI Acquires 31 Drug Products from Teva

December 26th, 2013

BAUDETTE, Minn., Dec. 26, 2013 – ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), an emerging generic pharmaceutical company, today announced that it has acquired 31 previously marketed generic drug products from Teva Pharmaceuticals for $12.5 million in cash and a percentage of future gross profits from product sales.  The acquisition includes 20 solid-oral immediate release products, 4Read more >

BioSante and ANI Complete Merger

June 20th, 2013

BAUDETTE, Minn.–(BUSINESS WIRE)– BioSante Pharmaceuticals, Inc. (BPAX) announced today that it has completed the merger of its wholly-owned subsidiary with and into ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. (ANI) in accordance with the terms of the amended and restated agreement and plan of merger, dated as of April 12, 2013. In connection with theRead more >

BioSante and ANI Announce Merger

October 4th, 2012

BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Merger Combined Company Will Focus on Specialty Branded and Generic Pharmaceutical Product Development, Manufacturing and Sales LINCOLNSHIRE, Illinois and Baudette, Minnesota (October 4, 2012) – BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. announced today that they have entered into a definitive merger agreementRead more >

Argentum Group

ADDITIONAL LINKS

  • Investors
  • Privacy / Terms

OUR LOCATION

60 Madison Avenue
Suite 701
New York, NY 10010

CONTACT INFO

Phone: 212.949.6262
Fax: 212.949.8294
info@argentumgroup.com
© 2017 Argentum Group. All Rights Reserved. Website Design by Web Full Circle.
  • ABOUT US
  • APPROACH
    • INVESTMENT STRATEGY
    • INVESTMENT CRITERIA
    • SECTORS
  • TEAM
  • PORTFOLIO
  • NEWS
  • INVESTORS
  • CONTACT US
Argentum